日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of novel mitochondrial pyruvate carrier inhibitors for breast cancer treatment.

开发用于乳腺癌治疗的新型线粒体丙酮酸载体抑制剂

Schumacher Tanner J, Gardner Zachary S, Rumbley Jon, Ronayne Conor T, Mereddy Venkatram R

Exploring the impact of mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 on breast cancer cell metabolism

探索线粒体靶向驱虫药GLUT1抑制剂BAY-876对乳腺癌细胞代谢的影响

Schumacher, Tanner J; Iyer, Ananth V; Rumbley, Jon; Ronayne, Conor T; Mereddy, Venkatram R

Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease

针对人类疾病中线粒体生物能量缺陷的适应性细胞反应

Bennett, Christopher F; Ronayne, Conor T; Puigserver, Pere

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

新型N-苯基吲唑基二芳基脲类化合物的合成、体外和体内评价及其作为潜在抗癌药物的活性

Solano, Lucas N; Nelson, Grady L; Ronayne, Conor T; Jonnalagadda, Shirisha; Jonnalagadda, Sravan K; Kottke, Kaija; Chitren, Robert; Johnson, Joseph L; Pandey, Manoj K; Jonnalagadda, Subash C; Mereddy, Venkatram R

Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

新型N,N-二烷基氰基肉桂酸作为单羧酸转运体1和4抑制剂

Jonnalagadda, Shirisha; Jonnalagadda, Sravan K; Ronayne, Conor T; Nelson, Grady L; Solano, Lucas N; Rumbley, Jon; Holy, Jon; Mereddy, Venkatram R; Drewes, Lester R

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

香豆素羧酸作为单羧酸转运体1抑制剂:体外和体内研究及其作为潜在抗癌药物的作用

Gurrapu, Shirisha; Jonnalagadda, Sravan K; Alam, Mohammad A; Ronayne, Conor T; Nelson, Grady L; Solano, Lucas N; Lueth, Erica A; Drewes, Lester R; Mereddy, Venkatram R